Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.
An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback